These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29604984)

  • 21. HIV-1 encephalopathy among perinatally infected children: Neuropathogenesis and response to highly active antiretroviral therapy.
    Mitchell CD
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):216-22. PubMed ID: 17061285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurologic consequences of HIV infection in the era of HAART.
    Sperber K; Shao L
    AIDS Patient Care STDS; 2003 Oct; 17(10):509-18. PubMed ID: 14588091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
    Hong S; Banks WA
    Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neurological manifestations of the HIV infection].
    Arendt G; Nolting T
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():75-7. PubMed ID: 16385884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe HIV-1 encephalitis and development of cerebral non-Hodgkin lymphoma in a patient with persistent strong HIV-1 replication in the brain despite potent HAART -- case report and review of the literature.
    Baeuerle M; Schmitt-Haendle M; Taubald A; Mueller S; Walter H; Pfeiffer C; Manger B; Harrer T
    Eur J Med Res; 2005 Jul; 10(7):309-16. PubMed ID: 16055403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of HIV infection from the neurologic viewpoint. Therapy must reach the brain].
    von Giesen HJ; Köller H; Arendt G
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():46-50. PubMed ID: 12043074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of HIV central nervous system persistence on pathogenesis.
    Brew BJ; Barnes SL
    AIDS; 2019 Dec; 33 Suppl 2():S113-S121. PubMed ID: 31790377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathology and HIV dementia.
    Pelle MT; Bazille C; Gray F
    Handb Clin Neurol; 2008; 89():807-18. PubMed ID: 18631796
    [No Abstract]   [Full Text] [Related]  

  • 29. Human immunodeficiency virus-associated dementia: an evolving disease.
    McArthur JC; Haughey N; Gartner S; Conant K; Pardo C; Nath A; Sacktor N
    J Neurovirol; 2003 Apr; 9(2):205-21. PubMed ID: 12707851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Wright EJ
    Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NeuroAIDS: diagnosis and management.
    McArthur JC
    Hosp Pract (1995); 1997 Aug; 32(8):73-4, 77-9, 84 passim. PubMed ID: 9275962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The electrophysiology of neuroHIV: A systematic review of EEG and MEG studies in people with HIV infection since the advent of highly-active antiretroviral therapy.
    Fernández-Cruz AL; Fellows LK
    Clin Neurophysiol; 2017 Jun; 128(6):965-976. PubMed ID: 28433855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Never too old.
    de Souza RK; Martins RT; da Rocha SF; Sato HK; Kowacs PA
    Lancet; 2011 Nov; 378(9803):1676. PubMed ID: 22055042
    [No Abstract]   [Full Text] [Related]  

  • 34. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.
    Zoufaly A; Stellbrink HJ; Heiden MA; Kollan C; Hoffmann C; van Lunzen J; Hamouda O;
    J Infect Dis; 2009 Jul; 200(1):79-87. PubMed ID: 19476437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial comment: treatment of HIV-associated cognitive impairment--beyond HAART.
    Parsons TD; Robertson KR
    AIDS Read; 2005 Jun; 15(6):293. PubMed ID: 15962452
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV-associated neurocognitive disorder.
    Smail RC; Brew BJ
    Handb Clin Neurol; 2018; 152():75-97. PubMed ID: 29604986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controversies in HIV-associated neurocognitive disorders.
    Nightingale S; Winston A; Letendre S; Michael BD; McArthur JC; Khoo S; Solomon T
    Lancet Neurol; 2014 Nov; 13(11):1139-1151. PubMed ID: 25316020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
    Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.
    Canestri A; Lescure FX; Jaureguiberry S; Moulignier A; Amiel C; Marcelin AG; Peytavin G; Tubiana R; Pialoux G; Katlama C
    Clin Infect Dis; 2010 Mar; 50(5):773-8. PubMed ID: 20100092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.